City
Epaper

G.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and Nutraceuticals

By ANI | Updated: June 6, 2025 17:28 IST

India PR DistributionMumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India's pharmaceutical, ...

Open in App

India PR Distribution

Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India's pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality.

What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL's impressive timeline of achievements includes:

- 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities

- 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals

- 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market

-2018: Entry into the sports nutrition space

- 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics

- 2023: Establishment of a dedicated vaccine division to expand immunization solutions

Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R&D, and a global network of manufacturing and distribution partners.

"At GCCPL, innovation is not a buzzwordit's the foundation of our growth strategy," said Founder and Chairman Gautam Shah. "We're proud to be one of India's few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer."

Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probioticboth showcasing GCCPL's commitment to introducing clinically backed, innovative health solutions to India.

With a sterling reputation for regulatory compliance, deep market research, and financial integrityas affirmed by CRISIL's highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products.

About G.C Chemie Pharmie Pvt. Ltd.

Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today's market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.

For queries -

Website: www.gccpl.com

(ADVERTORIAL DISCLAIMER: The above press release has been provided by India PR Distribution.will not be responsible in any way for the content of the same)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalDefence Secretary meets Israeli Defence Minister, signs MoU to boost India-Israel defence ties

International"Trump feels very strongly about India-US relationship": White House

InternationalThird India-Belgium Foreign Office Consultations reviews full spectrum of ties

CricketVirat Kohli turns 37: Deep dive into stunning numbers of India's all-format batting juggernaut

InternationalJaishankar meets Sri Lankan Opposition Leader Sajith Premadasa, discusses ties and regional cooperation

Business Realted Stories

BusinessPaytm reports strong Q2 with 24% revenue growth, PAT of Rs 211 crore, driven by robust business model, AI-led opportunities

BusinessPaytm’s net profit improves to Rs 211 crore in Q2, revenue up 24 pc

BusinessMehli Mistry steps down from Tata Trusts, recalls commitment to Ratan Tata

BusinessIndia-UK Science and Technology Partnership dashboard unveiled

BusinessWhen AI takes over, India will emerge as most influential civilisation: Report